CONMED Launches BioBrace®RC to Revolutionize Rotator Cuff Repair Surgeries

  • Published: 8/12/2025
  • 3 min

Release Date: August 12, 2025

CONMED Launches BioBrace®RC to Revolutionize Rotator Cuff Repair Surgeries
Proprietary arthroscopic delivery system designed to streamline surgical augmentation and enhance procedural performance using the FDA-cleared BioBrace® implant.

BioBraceRC applied to shoulder

LARGO, FL - August 12, 2025 – CONMED Corporation (NYSE: CNMD), a leading global medical technology company, has officially launched BioBrace®RC, a proprietary arthroscopic delivery system that simplifies augmentation of rotator cuff repairs with BioBrace® – the only FDA-cleared reinforced bioinductive implant. The system is designed to improve surgical efficiency, offering a complete augmentation procedure in under 10 minutes.

Building on the proven performance of BioBrace®, the new BioBrace®RC system integrates suture-based fixation for mechanical reinforcement and biological healing, all in a fully bioresorbable format. Designed to support a wide range of surgical techniques, BioBrace®RC helps optimize workflows by providing pre-assembled components that streamline preparation, delivery, and fixation during arthroscopic procedures.

“This innovation reimagines the procedure, making it more efficient and accessible for patients nationwide,” said Nate Miersma, Vice President & General Manager, US Orthopedics. “BioBrace®RC marks a pivotal moment in advancement for the surgical community and patient outcomes for years to come.”
BioBraceRC Delivery System
BioBraceRC 23x30 Pad

The BioBrace®RC arthroscopic delivery system simplifies the augmentation of rotator cuff repairs by streamlining the delivery of the BioBrace® implant – providing both mechanical reinforcement and promoting biological healing. The system supports surgeons throughout the procedure, from preparation to final fixation.

BioBrace®RC comes preloaded with the BioBrace® implant and features integrated suture management, including pre-assembled lateral sutures and a threader assembly that allows for simultaneous suture passage through the implant. After placing medial suture anchors and passing the sutures through the rotator cuff, the surgeon uses the threader mechanism to pull the sutures through the implant. The implant is then positioned at the repair site, the delivery system is removed, and fixation is completed by tying or laterally securing the sutures – all in a single, efficient workflow.

BioBrace® is composed of type I bovine collagen and PLLA (poly-L-lactic acid) microfilaments – fully bioresorbable materials that provide initial mechanical support and gradually transition to tissue. Since 2021, BioBrace® has been used in more than 14,000 patients and across more than 50 anatomical sites. It is FDA-indicated for use in surgical procedures to reinforce soft tissue where weakness exists.

"I've been putting in BioBrace® for several years now, and when this first was coming out, I said, 'I probably won't need that or use that,' just because I've got my system down. But let me tell you – I think I ate my words. It made suture management so easy. It made me think, 'Well, where's this been all my life?'"
— Stephan Pill, MD
For more information about the BioBrace®RC arthroscopic delivery system and its role in enhancing rotator cuff repair procedures, visit the BioBrace®RC product page or contact your local CONMED representative.

About CONMED

CONMED is a global medical technology company enabling healthcare providers worldwide to deliver exceptional outcomes for patients through accessible CONMED solutions. For over 50 years, CONMED has delivered outcome-impacting innovations to healthcare professionals across the globe. Through proprietary technologies and acquired brands, CONMED is committed to helping advance surgical outcomes.

Visit the official CONMED website to learn more